Consumer Health

Sales of dermatologicals strongly rely on consumers visiting pharmacies (the dominant distribution channel) as Belgians rarely go first to these stores specifically to purchase such products. Instead these are generally secondary purchases alongside…

Dermatologicals in Azerbaijan is recording an upward trajectory in 2023 but at a pace that could generously be called moderate, and notably slower in terms of volume sales compared to 2022. When it comes to dermatologicals, local consumer education…

Dermatologicals is seeing mid-single digit growth in current value terms in 2023, although like many areas of consumer health this is largely the result of price increases. Prices have been rising across all categories of dermatologicals as a result…

Dermatologicals is set to see a strong performance in 2023, with all the major categories seeing mid to high single-digit growth in retail current value terms. Antifungals (topical antifungals and vaginal antifungals) is one of the largest categories…

Retail sales of dermatologicals saw a second year of healthy growth in constant value terms in 2023. The category suffered a decline during the pandemic, when consumers spent more time at home and were therefore less exposed to environments which…

Skin diseases across all age groups continues to drive growth for dermatologicals. Skin diseases are common in rural areas due to poor hygiene and in urban areas due to overcrowded neighbourhoods, with many having no access to proper sanitary…

Interest in personalised approaches to health and beauty has surged since COVID-19, as improvements in technology have been met by a more accepting public focused on health outcomes and demanding products that fit their unique goals. Personalisation…

The report will explore the key themes transforming consumer behaviour in Asia Pacific in the world beyond the pandemic, namely Digital Living, Rethink Wellness, Sustainable Living, Make My Life Easier and Search for Experiences, and the strategies…

As the year comes to an end, this report captures the evolution of the sentiment, preparedness, impact, reaction and future measures taken by businesses during 2020 in response to the Coronavirus (COVID-19) pandemic, while also looks ahead to predict…

Vietnam has been experiencing a higher number of cases of influenza in 2023, which is benefiting sales of cough, cold and allergy (hay fever) remedies. Due to prolonged home seclusion as a result of pandemic-related restrictions, Vietnamese consumers…

Cough, cold and allergy remedies face favourable growth in 2023, with the category boosted by the return to normal social lifestyles post-pandemic. The regular circulation of seasonal cold viruses is fuelling demand, which had previously fallen due…

With value sales of cough and cold and allergy ( hay fever) remedies reducing to more normal levels. as concern about COVID-19 abate, there is expected to be a decline in volume sales in 2023. The exception being medicated confectionery. Along with…

Manufacturers have raised their prices due to the rising costs of energy, raw materials, production and logistics amid a highly inflationary climate. Nonetheless, in many cases, consumers have continued to buy the more expensive branded options as…

In Tunisia, there is a strong preference for unit-dose sachets among consumers when it comes to cough, cold and allergy (hay fever) remedies. This format is highly popular and widely used, with brands like Fervex, Gripex, and Doliprex being prominent…

Cough, cold and allergy (hay fever) remedies continued to enjoy healthy growth in current value terms in 2023. This was driven, to a large extent, by the revival of normal pre-pandemic patterns of behaviour, including the return of Thais to their…

Current value sales of cough, cold and allergy (hay fever) remedies rebounded to pre-pandemic levels in 2022 as the UK experienced its strongest cold and flu season in recent years, as a result of greater socialising as restrictions eased, thereby…

In 2023, cough, cold and allergy (hay fever) remedies is set to see dynamic current growth, on top of an extremely strong performance in 2022. Within the category, after medicated confectionery, growth is set to be driven by and paediatric cough/cold…

The increasingly dusty weather in the United Arab Emirates is causing a rise in allergies and respiratory illnesses amongst consumers. In particular, in August 2022 there were so many dust storms that doctors in Abu Dhabi and Dubai issued a warning…

In the Philippines, one interesting aspect of OTC products in general and cough, cold and allergy (hay fever) remedies in particular is that consumers are generally very aware of the active ingredients that are contained within these products and the…

Cough, cold, and allergy (hay fever) remedies is projected to continue to post retail current value growth in 2023, following a severe decline in 2020 due to the Coronavirus (COVID-19) pandemic. Having passed the 2019 pre-pandemic level in 2022, the…